Cite
P216: Evaluation of Public Health Contact Tracing for Mpox -- Ten U.S. Jurisdictions, May 17--July 31, 2022.
MLA
Cope, Anna B., et al. “P216: Evaluation of Public Health Contact Tracing for Mpox -- Ten U.S. Jurisdictions, May 17--July 31, 2022.” Sexually Transmitted Diseases, vol. 51, Jan. 2024, p. S232. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=176116060&authtype=sso&custid=ns315887.
APA
Cope, A. B., Bernstein, K., Cahill, M. E., Drociuk, D., Fox, B., Tingting Gu-templin, Hannibal, T., Harbi, K., Harrington, P., Jackson, D., Kirkcaldy, R. D., Klos, R., & Laramme, N. (2024). P216: Evaluation of Public Health Contact Tracing for Mpox -- Ten U.S. Jurisdictions, May 17--July 31, 2022. Sexually Transmitted Diseases, 51, S232.
Chicago
Cope, Anna B., Kyle Bernstein, Megan E. Cahill, Dan Drociuk, Brian Fox, Tingting Gu-templin, Terri Hannibal, et al. 2024. “P216: Evaluation of Public Health Contact Tracing for Mpox -- Ten U.S. Jurisdictions, May 17--July 31, 2022.” Sexually Transmitted Diseases 51 (January): S232. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=176116060&authtype=sso&custid=ns315887.